Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Zura Bio Ltd | 2,934,107 | reported | 21 Jan 2026 | tx 4+3,309,627 |
| Amanat Acquisition Corp. | 300,000 | reported | 20 May 2026 | tx 1+300,000 |
| Talaris Therapeutics, Inc. | 30,387 | reported | 28 Oct 2025 | tx 17+1,771,052−1,771,052 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2026 | PURCHASE | Amanat Acquisition Corp. | 300,000 | — | first after silence |
| 21 Jan 2026 | GRANT_AWARD | Zura Bio Ltd | 2,934,107 | 0.00 USD | deriv |
| 28 Oct 2025 | TENDER | Talaris Therapeutics, Inc. | 7,000 | — | |
| 28 Oct 2025 | OTHER | Talaris Therapeutics, Inc. | 30,387 | — | |
| 28 Oct 2025 | TENDER | Talaris Therapeutics, Inc. | 724,664 | — | |
| 28 Oct 2025 | OTHER | Talaris Therapeutics, Inc. | 503,478 | — | deriv |
| 28 Oct 2025 | OTHER | Talaris Therapeutics, Inc. | 226,000 | — | deriv |
| 28 Oct 2025 | OTHER | Talaris Therapeutics, Inc. | 254,207 | — | deriv |
| 22 Oct 2025 | EXERCISE | Talaris Therapeutics, Inc. | 25,316 | 7.90 USD | |
| 22 Oct 2025 | EXERCISE | Talaris Therapeutics, Inc. | 25,316 | 0.00 USD | deriv |
| 21 May 2025 | GRANT_AWARD | Zura Bio Ltd | 51,000 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | Talaris Therapeutics, Inc. | 226,000 | 0.00 USD | deriv |
| 09 Dec 2024 | GRANT_AWARD | Zura Bio Ltd | 117,000 | 0.00 USD | deriv |
| 21 Aug 2024 | PURCHASE | Talaris Therapeutics, Inc. | 1,779 | 14.85 USD | |
| 16 Aug 2024 | PURCHASE | Talaris Therapeutics, Inc. | 5,221 | 13.79 USD | |
| 17 Nov 2023 | PURCHASE | Talaris Therapeutics, Inc. | 4,000 | 16.99 USD | |
| 24 Oct 2023 | PURCHASE | Talaris Therapeutics, Inc. | 4,650 | 10.68 USD | |
| 26 Oct 2023 | PURCHASE | Talaris Therapeutics, Inc. | 5,000 | 12.25 USD | |
| 19 Oct 2023 | GRANT_AWARD | Talaris Therapeutics, Inc. | 716,085 | — | |
| 23 Oct 2023 | GRANT_AWARD | Talaris Therapeutics, Inc. | 254,207 | 0.00 USD | deriv |
| 19 Oct 2023 | GRANT_AWARD | Talaris Therapeutics, Inc. | 528,794 | — | deriv |
| 18 May 2023 | GRANT_AWARD | Zura Bio Ltd | 207,520 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 20 May 2026.